In addition, we chose to investigate the interaction of R-RAS2 with CD44 because it is considered an important marker of cancer stemness, because it is involved in EMT and because it promotes metastasis through interaction with the ECM, most importantly with hyaluronic acid [50–52]. Here, RRAS2 is linked to cancer.